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Human vascular smooth muscleThe phosphoinositol-phospholipase C (PLC) family of enzymes consists of a number of isoforms, each of which
has different cellular functions. PLCγ1 is primarily linked to tyrosine kinase transduction pathways, whereas
PLCδ1 has been associatedwith a number of regulatory proteins, including those controlling the cell cycle. Recent
studies have shown a central role of PLC in cell organisation and in regulating awide array of cellular responses. It
is of importance to deﬁne the precise role of each isoform, and how this changes the functional outcome of the
cell. Here we investigated differences in PLC isoform levels and activity in relation to differentiation of human
and rat vascular smooth muscle cells. Using Western blotting and PLC activity assay, we show that PLCδ1 and
PLCγ1 are the predominant isoforms in randomly cycling human vascular smooth muscle cells (HVSMCs).
Growth arrest of HVSMCs for seven days of serum deprivation was consistently associated with increases in
PLCδ1 and SMα-actin, whereas there were no changes in PLCγ1 immuno-reactivity. Organ culture of rat mesen-
teric arteries in serum freemedia (SFM), amodel of de-differentiation, led to a loss of contractility aswell as a loss
of contractile proteins (SM α-actin and calponin) and PLCδ1, and no change in PLCγ1 immuno-reactivity. Taken
together, these data indicate that PLCδ1 is the predominant PLC isoform in vascular smooth muscle, and conﬁrm
that PLCδ1 expression is affected by conditions that affect the cell cycle, differentiation status and contractile
function.
© 2013 The Authors. Published by Elsevier B.V. All rights reserved.1. Introduction
The phosphoinositol-phospholipase C (PLC) family of enzymes plays
an important role in trans-membrane signalling in response to many
hormones and growth factors. The primary function of PLC is to catalyse
the hydrolysis of phosphatidylinositol 4,5-bisphophate (PIP2) to gener-
ate inositol (1,4,5)triphosphate (IP3) and 1,2-diacylglycerol (DAG). IP3
initiates an increase in intracellular calcium,whereasDAG activates pro-
tein kinase C (PKC). Control over this important second messenger
pathway is key to changes in cellular activity and function.
The PLC family consists of a number of isoforms which regulate dif-
ferent cellular functions. PLCγ1 activity can be stimulated following
growth factor-binding to receptor-linked tyrosine kinases [1] and hasC; HVSMCs, human vascular
ly cycling
erms of the Creative Commons
which permits non-commercial
d the original author and source
gy, School of Life and Medical
eld AL10 9AB, UK. Tel.: +44 1
zie).
lished by Elsevier B.V. All rights resera well-established role in mitogenesis [2] and cell migration [3]. A re-
cent study indicates that PLCγ1 also has a key role in the control in hyp-
oxic Ca2+ regulation and contraction in mouse resistance pulmonary
arteries (and not mesenteric arteries) [4]. On the other hand, PLCδ1
has a role in norepinephrine-induced vascular smooth muscle contrac-
tion [5], has been implicated in hypertension [6], and is down-regulated
in gastric cancers [7]. PLCδ1 accumulates in the cell nucleus during the
G1/S boundary and in G0 phases in the cell cycle [8,9], following Ca2+ in-
ﬂux following ionomycin treatment [10], and accumulates at the cleav-
age furrow during cytokinesis [11]. Regulation of PLCδ1 is complex, and
various proteins, including transglutaminase [12], p122rhoA [13], and
Ral and calmodulin [14] have been reported to inﬂuence its activity. Re-
cent studies have indicated that PLCδ1 has a role in cytoskeletal organi-
sation as well as cell cycling, although a full understanding of its role is
lacking.
Differentiated vascular smooth muscle cells express a characteristic
proﬁle of proteinswhich are essential for contractile function. Following
cell culture however, these cells dedifferentiate, lose their contractile
ability and exhibit altered expression of contractile proteins such as
smooth muscle (SM) α-actin and calponin. PLCδ1 and PLCγ1 have been
identiﬁed in smooth muscle, although their association with smooth
muscle cell differentiation has not been investigated. The objective of
this study was to investigate the proﬁle of PLC isoforms in humanved.
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ciated changes in PLC isoforms following an increase in differentiation by
incubation in serum free conditions. This is compared to changes in PLC
isoform proﬁle in a secondmodel where cultured rat mesenteric arteries
lose their ability to contract and the associated changes of PLC isoforms
are measured.
2. Materials & methods
2.1. Collection of human and rat tissues
Anonymised discarded tissue samples of saphenous vein were
obtained following surgery and the study was approved by St. Mary's
Hospital, Imperial College local research ethics committee and conducted
according to the principles expressed in the Declaration of Helsinki. Tis-
sues were obtained in 1998 and 1999. Permission to use the tissues was
verbally given, which at the time was approved by St. Mary's, Imperial
College ethical committee.
The care and use of all rats in this study was carried out in accordance
with UK Home Ofﬁce regulations, UK Animals (Scientiﬁc Procedures) Act
of 1986, and the ethical review committee of Imperial College London ap-
proved this study.
2.2. Vascular smooth muscle cell culture
HVSMCs were cultured in DMEM buffered with 25 mM HEPES and
supplemented with 15% (vol./vol.) foetal calf serum (FCS), 4 mM
L-alanyl-L-glutamine (Glutamax-I), 100 U/ml penicillin, 100 μg/ml
streptomycin, and 25 μg/ml gentamicin using an explant technique as
previously described [15] and characterised as HVSMC on the basis of
immuno-cytochemistry. Cell cultures were maintained in a humidiﬁed
atmosphere of 5% CO2 (vol./vol.) in air at 37 °C. HVSMCswere routinely
used at third passage at a density of 106 cells per 75 cm2 ﬂask unless
otherwise stated.
2.3. Modulation of phenotypic status
Passage twoHVSMCswere plated onto either 75 cm2 ﬂask (106 cells)
or sterile cover slips (2 × 104 cells/slip) and allowed to attach for 24 h
in DMEM supplemented with 15% (vol./vol.) FCS. Cells maintained in
DMEM supplementedwith 15% FCSwere routinely used as randomly cy-
cling, control cells. Cells were washed twice with phosphate buffered sa-
line (PBS) prior to incubation in serum-free NCTC containing 25 mM
HEPES, 4 mM Glutamax-I, 100 U/ml penicillin, 100 μg/ml streptomycin,
25 μg/ml gentamicin and 25 mg/ml bovine serum albumin, which is re-
ferred to as serum free media (SFM).
2.4. Preparation of cell lysates
HVSMCs were washed twice with ice-cold PBS and scraped into
1 ml of ice-cold lysis buffer (50 mM Tris (pH 7.4); 150 mM NaCl;
1 mM EGTA; 1% (vol./vol.) NP-40; 0.25% sodium deoxycholate; 1 mM
sodium ﬂuoride, sodium orthovanadate, phenylmethylsulphonyl ﬂuo-
ride; 1 μg/ml aprotinin, pepstatin, leupeptin) [16,17]. This lysate was
vortexed and allowed to stand on ice for 10 min prior to centrifugation
(14,000 rpm, 15 min, 4 °C). The protein concentration of the resulting
supernatants was determined using the Bradford method.
2.5. Immunoprecipitation
HVSMC cellular protein (200 μg) was removed from all samples and
pre-cleared for 1 h with 50 μg albumin-agarose, prior to incubation
with antibody (1 μg antibody/100 μg protein) for 3 h at 4 °C. Immu-
noprecipitates were captured on protein A-agarose as previously de-
scribed [16].2.6. Immunoblotting
Proteins were separated on 10% SDS-polyacrylamide gels prior to
transfer to nitrocellulose using a Bio-Rad wet gel transfer system. Fol-
lowing successful transfer nitrocellulose blots were blocked in 5% BSA
for 1 h and washed three times in Tris buffered saline containing 0.05%
Tween 20 (TTBS), prior to probing with primary antibody for 1 h. Blots
were washedwell in TTBS before being probedwith the appropriate sec-
ondary antibody and developed using enhanced chemiluminescence.
2.7. DNA synthesis assays
DNA synthesis was determined by measuring the incorporation of
[methyl 3H]-thymidine into acid insoluble material [18]. Cells were ei-
ther maintained in serum-supplemented DMEM or placed in serum-
free NCTC for 1, 3, 5 and 7 days prior to assay; [methyl 3H]-thymidine
at 1 μCi per well (5 μCi/ml) was added to eachwell for a six hour period
and the experiment was terminated with 10% (wt./vol.) trichloroacetic
acid.
2.8. Semi-quantitative PCR
cDNA was prepared from DNase-treated total RNA using the
Omniscript RT kit that was ampliﬁed using glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) primers by PCR and this was used to normalise
cDNA for PCR with other primers. Primers used were: GAPDH sense (5′-
TCCCCACTGCCAACGTGTCAG-3′), antisense (5′-GTTGTCATACCAGGAAAT
GAGC-3′); PLCδ sense (5′-TGCCAGATCGTGGCCCTGAATTTCCAGACAC-
3′), antisense (5′-CCTTGCTTGAGGCTGTTCAAGGGGATGGTAC-3′); PLCγ
sense (5′-GGAGCTGAGTATGACAGCACCAAGC-3′), antisense (5′-AGAG
GCGGTTGTCTCCATTGACC-3′).
2.9. Immunoﬂuorescence
HVSMCs grown on sterile cover slips were washed twice with PBS
prior to ﬁxing in 100% methanol for 10 min before being allowed to
air dry. Cover slips were then blocked in PBS containing 0.1% of
BSA (bovine serum albumin) and 0.1% Triton X-100 (TPBS) for 1 h
before the addition of primary antibody (1:50 in blocking solution)
for 1 h at room temperature (SM α-actin, PLCγ1) or overnight at 4 °C
(PLCδ1). These were then washed three times in TPBS before the addi-
tion of the appropriate secondary antibody. Cover slips were then
washed,mounted onto glass slides and viewed using a Leica TCS SP con-
focal microscope. Due to the relatively ﬂat nature of these HVSMCs in
culture all images shown are maximum projection.
2.10. Measurement of PLC activity
PLC activity was measured using the method previously described
[13,19]. Brieﬂy 30 μl aliquots of protein samples were assayed for PLC
activity in a ﬁnal volume of 100 μl containing PLC buffer (20 mM Tris,
pH 7.0, 100 mM NaCl, 2 mM EGTA, 2.4 mM MgCl2, 8 mM CaCl2 and
0.05% BSA). The assay was initiated by the addition of 10 μl substrate
(unilamellar vesicles containing 350 μM PI, 360 μM phosphatidyletha-
nolamine, 0.015 μCi [3H]-PI). Following a 10 min incubation at 37 °C
the reaction was terminated by the addition of 0.5 ml ice-cold chloro-
form:methanol:HCl (10:10:0.06) followed by 0.15 ml 1 M HCl contain-
ing 5 mMEGTA. Sampleswere vortexed and then left on ice for 10 min.
Aliquots of the aqueous phase containing water-soluble hydrolysis
products were counted in a Liquid Scintillation Analyser.
2.11. Rat mesenteric artery organ culture
MaleWistar rats (250–300 g)were killed by cervical dislocation and
the mesentery isolated. Second or third order branches of the superior
mesenteric artery (internal diameter ~200–300 μm) were dissected,
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Bijou bottles containing 5 ml SFM. Vessels were incubated at 37 °C
under 5% CO2 in a water-jacketed incubator for up to 4 days.
2.12. Isometric myography
Fresh or cultured mesenteric arteries were mounted as ring seg-
ments in an isometric wire myograph [20] in physiological salt solution
(PSS; 119 mM NaCl, 4.7 mM KCl, 2.5 mM CaCl2, 1.17 mM MgSO4,
25 mM NaHCO3, 1.18 mM KH2PO4, 0.027 mM EDTA, 5.5 mM glucose)
maintained at 37 °C and aerated with 95% oxygen/5% carbon dioxide.
All vessels were allowed to equilibrate for 1 h prior to being set at a
‘normalised’ internal circumference 0.9.L100 estimated to be 0.9 times
the circumference they would maintain if relaxed and exposed to
100 mm Hg transmural pressure. This was calculated for each individu-
al vessel on the basis of passive length-tension characteristics of the ar-
tery and the Laplace relationship [20]. All experiments were initiated by
repetitively stimulating vessels for approximately 2 min with a high
potassium solution (KPSS; 124 mM, 2.5 mM CaCl2, 1.17 mM MgSO4,
25 mM NaHCO3, 1.18 mM KH2PO4, 0.027 mM EDTA, 5.5 mM glucose)
until reproducible contractions were elicited. After washout and recov-
ery as appropriate, vessels were then stimulated with norepinephrine
(NE; 10 μM) and then 5-hydroxytryptamine (5-HT; 10 μM).
2.13. Protein preparation & analysis of rat mesenteric arteries
Preparation of protein samples from whole vessels was performed
as described by Lindqvist et al. [21] with minor modiﬁcations. Brieﬂy,
fresh and cultured vessels were rinsed well in PSS and cut into 2 mm
lengths under the dissecting microscope. Equal numbers of vessels
were then placed into Eppendorf tubes containing SDS sample buffer
(62.5 mM Tris–HCl, 2% SDS, 10% glycerol, 5% 2-mercaptoethanol, 0.001%
bromophenol blue) and microwaved for 2 min on full power (1100 W),
cooling on ice every 15 s. Sampleswere thenboiled for 10 min and cooled
on ice prior to protein separation andWestern blotting [16]. For purposes
of subsequent analysis, protein immuno-reactivity in freshmesenteric ar-
terieswas taken to be 100% and immuno-reactivity in all cultured arteries
was calculated with respect to this.
2.14. Confocal imaging of rat mesenteric arteries
Fresh and cultured vessels were mounted as ring segments in the
isometric myograph prior to being ﬁxed in 4% paraformaldehyde solu-
tion in calcium-free PSS for 15 min at room temperature. Fixed vessels
were dissected longitudinally and washed in PBS (phosphate buffered
saline) containing 0.1% vol./vol. Triton X-100 (TPBS) at 4 °C overnight
prior to incubation with primary antibody for 18 h at 4 °C. Vessels
were then washed thoroughly in TPBS prior to incubation with second-
ary antibody for 4 h at room temperature. Following this vessels were
washed 4 times for 15 min in TPBS at room temperature with 20 nM
4′-6-diamidino-2-phenylindole (DAPI) being added in the ﬁnal wash.
Vessels were thenmountedﬂat, with adventitia facing upwards. Images
of the upper adventitial layer and the smooth muscle cell layer were
taken with Leica confocal microscope, and the images analysed using
Leica Application Suite Advance Fluorescence Lite software. Images
were taken of the same section, using the confocal lenses to move
through the Z plane. Confocal settings remained the same for all images
taken. Images from the inner endothelial cell layer were not recorded as
these cells are no longer present following organ culture for 4 days.
2.15. Analysis of data
All data are represented as the mean ± SEM of n observations. Sta-
tistical comparisons of data were made using Student's t-test for single
paired comparisons or one-way repeated measures of variance withBonferroni's post-hoc test using GraphPad InStat 4.0 as appropriate. p
values of less than 0.05 were considered statistically signiﬁcant.
2.16. Material
Cell culture materials and foetal calf serum were obtained from Life
Technologies. Bovine serum albumin fraction V was from Boehringer
Mannheim. Hybond C nitrocellulose, streptavidin complex and ECL-
ﬁlm were from Amersham. Antibodies to PLCβ2, β3, β4, γ2 and δ2 were
obtained from Insight Biotechnology Ltd, and all other antibodies were
obtained from TCS. Chemiluminescence reagents were obtained from
National Diagnostic and Protein-A agarose was from Cambridge Biosci-
ence. All other reagents were obtained from Sigma.
3. Results
3.1. Characterisation of PLC isoform proﬁle in HVSMCs
The proﬁle of PLC isoform immuno-reactivity in saphenous vein-
derived HVSMC was investigated using Western blotting techniques.
PLC isoforms β1, β2, β3, β4, γ1, γ2, δ1 and δ2 were all detected in samples
of rat brain but only PLCγ1 and PLCδ1 immuno-reactivity were detected
in either fresh saphenous vein, or saphenous vein-derived HVSMC ly-
sates (Fig. 1A).
Immuno-precipitation of either PLCδ1 or PLCγ1 from randomly cy-
cling cell lysates resulted in a markedly reduced PLC activity (Fig. 1B),
and indicated clearly that the majority if not all PLC activity in these
cells can be accounted for by these two isoforms. Consequently investi-
gations into the relative changes in immuno-reactivity of PLC isoforms
with modulation of differentiation status were limited to PLCγ1 and
PLCδ1.
In contrast, analysis of mRNA expression using semi-quantitative
RT-PCR techniques indicates that PLCδ1mRNA and PLCγ1 mRNA are
unchanged by 7 days of serum deprivation (Fig. 1C and D).
3.2. Temporal effects of serum deprivation on DNA synthesis and PLC
immuno-reactivity
Incorporation of [3H]-thymidine was measured in both randomly
cycling and serum deprived HVSMCs.While the level of [3H]-thymidine
incorporation was high in randomly cycling cells it dropped signiﬁcant-
ly 24 h post serum deprivation, and remained low until day 7 (Fig. 2A).
SM α-actin immuno-reactivity of serum deprived HVSMCs was not
signiﬁcantly different to that seen in randomly cycling control cells
over the ﬁrst 5 days of serum deprivation. However at 7 days post-
serum deprivation SM α-actin immuno-reactivity was signiﬁcantly in-
creased above the level seen in control cells (Fig. 2B). Similarly PLCδ1
immuno-reactivity in serum deprived cells was similar to that seen in
control cells over the ﬁrst ﬁve days but was signiﬁcantly elevated by
7 days post serum deprivation (Fig. 2B). PLCγ1 immuno-reactivity
levels on the other hand clearly began to decline compared to control
cells immediately following serumdeprivation although this did not be-
come statistically signiﬁcant until day 7 (Fig. 2B).
The level of immuno-reactivity of the contractile proteins SM α-actin
and calponin are generally accepted to be independent markers of differ-
entiation status in HVSMC. Consequently the immuno-reactivity of these
proteins was used to examine the effect of agents used to induce pheno-
typic modulation. The relative immuno-reactivity of PLCγ1 and PLCδ1
isoforms was examined in parallel to this and compared to control, ran-
domly cycling cells.
In randomly cycling cells SM α-actin formed an array of diffuse thin
actin ﬁlaments which although relatively unstructured were nonethe-
less visible throughout the cytoplasm. Following prolonged (7-day)
serum deprivation SM α-actin formed a clearly deﬁned structure with
distinct long, thick ﬁbres running the length of the cells. The staining
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Fig. 1. PLC proﬁle of human vascular smoothmuscle cells (HVSMCs). A.Western blot showing the immuno-reactivity of speciﬁc PLC isoforms in lysates (30 μg total protein) from 1) fresh
and 2) cultured human saphenous vein smoothmuscle cells (second passage) and 3) lysate of rat brain. Extracts fromeither fresh saphenous vein or secondary passaged cellswere probed
with primary antibody followed by secondary antibody (rabbit anti-mouse-HRP— PLCβ1, PLCδ1, PLCγ1, swine anti-rabbit-HRP— PLCβ2, PLCβ3, PLCβ4, PLCδ2, PLCγ2). B. PLC activity in ly-
sates of randomly cycling (RC) HVSMC following immuno-precipitation with goat (control), PLCδ1 and PLCγ1 antibodies. PLC activity in lysates treated with goat antibody (control) was
taken as100%.Data is shownas themean ± SEM(n = 5–6). Signiﬁcance of p ≤ 0.05 by onewayANOVA followedbyBonferroni'smultiple comparisonpost hoc test is indicatedby * compared
to a theoretical median in randomly cycling cells (RC) of 100%.
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than at the cell periphery (Fig. 3).
These changes were paralleled by a clear shift in PLCδ1 localisation
from the perinuclear region to the entire cytoplasmic region. PLCδ1
also appeared to take on a more structured appearance in growth
arrested cells, with the formation of some distinct ﬁbres, which might
be suggestive of some association with the structural components of
the cell (Fig. 3). PLCγ1 on the other hand demonstrated a very structured
appearance in randomly cycling control cells with ﬁbres appearing to run
the length of the cell. In serumdeprived cells however PLCγ1 bindingwas
dramatically reduced, largely restricted to the perinuclear region and of a
more granular appearance (Fig. 3). Dual staining of PLCδ1 and SMα-actinRC 1 3 5 7
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Fig. 2. Temporal changes during growth arrest to DNA replication and expression of proteins A.
randomly cycling cells and following serum deprivation for 1, 3, 5 and 7 days compared to rand
lines; 6 replicates). B. Changes in immuno-reactivity of SMα-actin, PLCδ1 and PLCγ1 over seven
on days 1, 3, 5 and 7 following serum free media treatment compared to randomly cycling cell
GAPDH, PLCδ1 and PLCγ1 in randomly cycling (RC) cells, and cell's serum deprived for 7 day
mean ± SEM; ns indicates no signiﬁcant difference by one way ANOVA, n = 8.shows that changes in distribution clearly changewith increases in differ-
entiation of the cell, but there is no evidence of co-localisation between
these proteins.3.3. Temporal effects of organ culture on force generation by rat mesenteric
artery
The contractile force of all cultured vessels, in response to a high
[K+] (Fig. 4A) solution, NA (Fig. 4B) and 5-HT (Fig. 4C) was maintained
for the ﬁrst 3 days, but was signiﬁcantly different by day 4 when com-
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HVSMC (SFM) taken on day 7 of culture. Blue DAPI staining indicates the nuclear staining. Images presented are maximum projection images (×630) obtained from a single experiment
and are representative of n = 3–4 separate experiments with cells from different individuals.
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mesenteric arteries
Following 4 days of culture in SFM, rat mesenteric arteries have a
signiﬁcant decrease in SM α-actin, calponin and PLCδ1 immuno-
reactivity compared to fresh arteries (Fig. 4C and D). In contrast, the
immuno-reactivity of PLCγ1 was not signiﬁcantly altered in vessels cul-
tured in SFM compared to fresh vessels (Fig. 4C and D).
3.5. Confocal microscopy
Immuno-reactivity to PLCδ1 was clearly detected in both the adventi-
tial and medial layers of fresh rat mesenteric arteries. Organ culture in0 1 2 3 4
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of PLCδ1 in the smooth muscle cell layer and adventitia (Fig. 5A and B).
PLCγ1 protein immuno-reactivity was detected in the adventitia and
smoothmuscle cell layers of fresh vessels. The intensity of PLCγ1 staining
in smoothmuscle cellswas not signiﬁcantly altered in vessels cultured for
4 days in SFM (Fig. 5A and C), and was signiﬁcantly reduced in the
adventitia.
4. Discussion
The PI-PLC family of enzymes is keymediator in the signal transduc-
tion of a great array of agonists, and has a central role in cellular func-
tion. As a family they are ubiquitous, although it is now clear that cells2 3 4
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express functional PLCδ1 and PLCγ1 and no other PLC isoform. However,
HVSMCs are not representative of the entire cardiovascular system, for
example other studies have clearly shown that mouse heart cell lines
express predominately PLCβ isoforms [22], whereas HUVECs express
all known isoforms except for PLCβ1, PLCε and PLCξ [23] and that ex-
pression of each isoform changes considerably following initiation of in-
ﬂammatory response to LPS challenge [24].
Of all the PLC isoforms looked for in fresh saphenous vein and thede-
rived cultured cells, only immuno-reactivity of PLCδ1 and that of PLCγ1
were detectable, and the activity of these two isoforms accounts for
the total activity of cellular PLC. This is in keeping with what has previ-
ously been reported, where PLCδ1 is the predominant isoform in blood
vessels and primary cultured rabbit aortic VSMC [25,26], which ismark-
edly up-regulated by growth arrest by long term serum free conditions.
In comparison, PLCγ1 immuno-reactivitywas reduced compared to ran-
domly cycling cells in these studies.
In contrast to the changes in immuno-reactivity and PLC activity, the
mRNA expression of PLCδ1 and PLCγ1 remained the same after 7 days of
serum deprivation. This is in keeping with previous ﬁndings, where
PLCδ1 and PLCγ1 mRNA levels did not correlate with protein expression
and activity in a rat heart model [27].
The inability to detect PLCβ isoforms in HVSMC is consistent with
previous reports by other groups who failed to detect PLCβ in rat, rabbit
or bovine aorta [25,26,19,28]. In contrast two studies have demonstrated
the presence of isoforms of PLCβ in porcine aorta [29] and immortalised
human aortic cells [30].Perhaps more importantly, temporal analysis of the changes in PLC
isoform immuno-reactivity following serum deprivation of HVSMCs in-
dicated differences in the time course of change in PLCδ1 and PLCγ1. An
increase in PLCδ1 immuno-reactivity did not occur until several days
post-growth arrest, which exhibited a temporal proﬁle very similar
to that of the increase in SM α-actin; whereas changes in PLCγ1
immuno-reactivity were evident 24 h following serum removal,
which corresponded with themost marked reduction in thymidine up-
take. Furthermore, the sub-cellular localisation of these PLC isoforms
differed in randomly cycling cells and was differentially affected by
prolonged serum deprivation. In randomly cycling cells PLCδ1 was
expressed throughout the cytoplasm; following serum deprivation ex-
pression was increased, and took on a more granular appearance in
the perinuclear regions of the cells. This is in keeping with the reported
changes in nuclear and perinuclear accumulation of PLCδ1 throughout
the cell cycle in ﬁbroblasts [31]. In contrast, PLCγ1 immuno-reactivity
was located throughout the cytoplasm, in a ﬁlamentousmanner in ran-
domly cycling cells, and was more evident in the perinuclear region
after serum deprivation. Serum deprivation resulted in changes in SM
α-actin and calponin organisation similar to those reported previously
in differentiated vascular smooth muscle cells in culture [32].
The cultured rat mesenteric artery is a model of loss of contractility
and decreasing smooth muscle differentiation. Loss of contractility in rat
mesenteric arteries was associated with a reduction of SM α-actinand
calponin as anticipated. PLCδ1 was highly expressed in fresh vascular
tissue [25,26] and both Western blotting and confocal studies indicated
that there was a marked reduction in PLCδ1 and no change in PLCγ1
3012 L.S. Mackenzie et al. / Biochimica et Biophysica Acta 1833 (2013) 3006–3012associatedwith organ culture. Loss of contractilitywas not coupled to any
signiﬁcant increases in the level of apoptosis of smooth muscle cells
(data not shown). There was a close temporal relationship between
the reduction in PLCδ1 immuno-reactivity and reduced contractility
and it is therefore tempting to suggest that these two phenomena
may be mechanistically related, although this hypothesis requires fur-
ther study.
The data presented here is theﬁrst to show the PLC isoformproﬁle of
fresh and cultured human saphenous vein smooth muscle cells. Our
ﬁndings show that changes in PLCδ1have a functional signiﬁcance, and
suggest that preventing the loss of PLCδ1 activity from smooth muscle
cells may have beneﬁcial effects.
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